G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/556 (2006.01) C07K 14/705 (2006.01)
Patent
CA 2571517
We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, the method comprising determining whether a candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which the Gpr100 polypeptide comprises the amino acid sequence shown in SEQ ID NO. 3 or SEQ ID NO. 5, or a sequence which is at least 90% identical thereto.
L'invention porte sur un procédé d'identification d'une molécule appropriée au traitement, à la prophylaxie ou au soulagement d'une maladie associée à Gpr100, en particulier le diabète et l'obésité : Le procédé consiste à déterminer si une molécule candidate est un agoniste ou un antagoniste du polypeptide Gpr100, le polypeptide Gpr100 comprenant la séquence d'acides aminés présentée dans le NO ID SEQ. 3 ou NO ID SEQ. 5 ou une séquence qui est au moins 90 % identique à celle-ci.
Aparicio Samuel
Dixon John
Hendrick Alan
Horwood Jennifer Marie
Zahn Dirk
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Paradigm Therapeutics Limited
LandOfFree
Uses of gpr100 receptor in diabetes and obesity regulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of gpr100 receptor in diabetes and obesity regulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of gpr100 receptor in diabetes and obesity regulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1812631